World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
101
Citations
40339
World Ranking
7933
National Ranking
457

Peter Vajkoczy publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter Vajkoczy sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 885 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter Vajkoczy D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter Vajkoczy sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 101 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter Vajkoczy is affiliated with Charité - University Medicine Berlin in Germany. Their research spans a broad range of topics within medicine, focusing particularly on neurology and surgery.

The main fields of study covered in Vajkoczy's work include medicine, with key subfields of neurology, surgery, epidemiology, radiology, nuclear medicine and imaging, and genetics. Their research is notably concentrated on specific topics such as glioma diagnosis and treatment, traumatic brain injury and neurovascular disturbances, intracranial aneurysms including their treatment and complications, meningioma and schwannoma management, spine and intervertebral disc pathology, brain metastases and treatment, and advanced neuroimaging techniques and applications.

Among their frequent co-authors are Julia Onken, Thomas Picht, Nils Hecht, Güliz Acker, and Lars Wessels, reflecting considerable collaborative activity in their research projects.

Vajkoczy has published numerous papers in various scientific venues. Notable recent publications include:

  • "The genomic and transcriptional landscape of primary central nervous system lymphoma," 2022, Nature Communications
  • "Effectiveness of Lumbar Cerebrospinal Fluid Drain Among Patients With Aneurysmal Subarachnoid Hemorrhage," 2023, JAMA Neurology
  • "The Genetic Basis of Moyamoya Disease," 2021, Translational Stroke Research
  • "Fluid balance and outcome in critically ill patients with traumatic brain injury (CENTER-TBI and OzENTER-TBI): a prospective, multicentre, comparative effectiveness study," 2021, The Lancet Neurology
  • "Spreading depolarizations in ischaemia after subarachnoid haemorrhage, a diagnostic phase III study," 2021, Brain

The venues where Vajkoczy has most frequently published include Brain and Spine, Neuro-Oncology, Acta Neurochirurgica, Die Wirbelsäule, and the Journal of Neurosurgery. These reflect a consistent focus on neurosurgical and neurological research.

Best Publications

  • Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research

    Andrew I R Maas;David K Menon;P David Adelson;Nada Andelic

  • Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation.

    Ulrike Fiedler;Yvonne Reiss;Marion Scharpfenecker;Verena Grunow

  • The movers and shapers in immune privilege of the CNS

    Britta Engelhardt;Peter Vajkoczy;Roy O Weller

  • Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)

    R Loch Macdonald;Randall T Higashida;Emanuela Keller;Stephan A Mayer

  • Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms

    Ralf Erber;Andreas Thurnher;Alice D. Katsen;Gesine Groth

  • SU6668 Is a Potent Antiangiogenic and Antitumor Agent That Induces Regression of Established Tumors

    A. Douglas Laird;Peter Vajkoczy;Laura K. Shawver;Andreas Thurnher

  • Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage

    Jens P. Dreier;Sebastian Major;Andrew Manning;Johannes Woitzik

  • Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial

    Ulrich Herrlinger;Theophilos Tzaridis;Frederic Mack;Joachim Peter Steinbach

  • Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought.

    Ryszard M. Pluta;Jacob Hansen-Schwartz;Jens Dreier;Peter Vajkoczy

  • Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI: a European prospective, multicentre, longitudinal, cohort study

    Ewout W. Steyerberg;Ewout W. Steyerberg;Eveline Wiegers;Charlie Sewalt;Andras Buki

  • The unruptured intracranial aneurysm treatment score: A multidisciplinary consensus

    Nima Etminan;Robert D. Brown;Kerim Beseoglu;Seppo Juvela

  • High-Mobility Group Box 1 Activates Integrin-Dependent Homing of Endothelial Progenitor Cells

    Emmanouil Chavakis;Andreas Hain;Maria Vinci;Guillaume Carmona

  • Cathepsin L is required for endothelial progenitor cell-induced neovascularization.

    Carmen Urbich;Christopher Heeschen;Alexandra Aicher;Ken-ichiro Sasaki

  • α4-integrin-VCAM-1 binding mediates G protein–independent capture of encephalitogenic T cell blasts to CNS white matter microvessels

    Peter Vajkoczy;Melanie Laschinger;Britta Engelhardt

  • Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.

    Peter Vajkoczy;Bernhard Meyer;Stefan Weidauer;Andreas Raabe

  • Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries.

    K Fassbender;B Hodapp;S Rossol;T Bertsch

  • Intraoperative control of extracranial-intracranial bypass patency by near-infrared indocyanine green videoangiography.

    Johannes Woitzik;Peter Horn;Peter Vajkoczy;Peter Schmiedek

  • Inositol-requiring enzyme 1α is a key regulator of angiogenesis and invasion in malignant glioma

    Gregor Auf;Gregor Auf;Gregor Auf;Arnaud Jabouille;Arnaud Jabouille;Sylvaine Guérit;Sylvaine Guérit;Raphaël Pineau

  • Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.

    Elke Muench;Peter Horn;Christian Bauhuf;Harry Roth

  • MGMT promoter methylation is a strong prognostic biomarker for benefit from dose-intensified temozolomide rechallenge in progressive glioblastoma: the DIRECTOR trial

    Michael Weller;Ghazaleh Tabatabai;Bärbel Kästner;Joerg Felsberg

Frequent Co-Authors

Jens P. Dreier
Jens P. Dreier Charité - University Medicine Berlin
Axel Ullrich
Axel Ullrich Max Planck Institute of Biochemistry
Andreas Raabe
Andreas Raabe University of Bern
M.D. Menger
M.D. Menger Saarland University
Wolfgang Wick
Wolfgang Wick German Cancer Research Center
Aarno Palotie
Aarno Palotie University of Helsinki
Helmuth Steinmetz
Helmuth Steinmetz Goethe University Frankfurt
Ewout W. Steyerberg
Ewout W. Steyerberg Leiden University Medical Center
Britta Engelhardt
Britta Engelhardt University of Bern
Stephan A. Mayer
Stephan A. Mayer New York Medical College

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in healthcare but aren't ready to pursue a traditional, lengthy medical degree, many flexible online alternatives are available. For those with an interest in the administrative side of medicine, medical coding certification online can lead to in-demand work in clinics, hospitals, and insurance companies.

Nursing is another rapidly growing field with varied online study options. Prospective registered nurses may wonder, what is the cheapest online college for nursing? Many accredited programs now offer affordable, flexible paths to a nursing degree. For those seeking higher qualifications, affordable online fnp programs allow registered nurses to advance their clinical skills and pursue family nurse practitioner roles.

Ambitious nurses interested in research, education, or leadership can explore online nursing doctoral programs to reach the highest levels of the profession. With so many remote study options, you can build a rewarding career in healthcare while balancing work and other commitments.

Best Scientists Citing Peter Vajkoczy

Trending Scientists

Recently Published Articles